Atticus Pharma Announces Initiation of the First Human Clinical Trial of ATC-002
ATC-002 is an Investigational Pharmaceutical Product Candidate for Androgenic Alopecia GREENVILLE, SC, UNITED STATES, April 14, 2025 /EINPresswire.com/ -- • ATC-002 is a twice-daily treatment designed to stimulate new hair growth in people …